Pfizer Inc (PFE)
27.72
-0.22
(-0.79%)
USD |
NYSE |
Mar 18, 16:00
27.72
0.00 (0.00%)
After-Hours: 20:00
Pfizer Gross Profit (Quarterly): 6.686B for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 6.686B |
September 30, 2023 | 3.963B |
June 30, 2023 | 9.497B |
March 31, 2023 | 13.40B |
December 31, 2022 | 14.64B |
September 30, 2022 | 16.58B |
June 30, 2022 | 19.09B |
March 31, 2022 | 15.68B |
December 31, 2021 | 14.10B |
September 30, 2021 | 14.10B |
June 30, 2021 | 11.90B |
March 31, 2021 | 10.36B |
December 31, 2020 | 8.716B |
September 30, 2020 | 8.27B |
June 30, 2020 | 8.038B |
March 31, 2020 | 8.143B |
December 31, 2019 | 1.40B |
September 30, 2019 | 10.08B |
June 30, 2019 | 10.69B |
March 31, 2019 | 10.68B |
December 31, 2018 | 341.00M |
September 30, 2018 | 10.60B |
June 30, 2018 | 10.55B |
March 31, 2018 | 10.34B |
December 31, 2017 | 10.45B |
Date | Value |
---|---|
September 30, 2017 | 10.32B |
June 30, 2017 | 10.24B |
March 31, 2017 | 10.31B |
December 31, 2016 | 10.42B |
September 30, 2016 | 9.96B |
June 30, 2016 | 9.973B |
March 31, 2016 | 10.15B |
December 31, 2015 | 10.64B |
September 30, 2015 | 9.868B |
June 30, 2015 | 9.673B |
March 31, 2015 | 9.026B |
December 31, 2014 | 10.42B |
September 30, 2014 | 9.993B |
June 30, 2014 | 10.31B |
March 31, 2014 | 9.308B |
December 31, 2013 | 10.76B |
September 30, 2013 | 10.36B |
June 30, 2013 | 10.73B |
March 31, 2013 | 10.15B |
December 31, 2012 | 11.14B |
September 30, 2012 | 10.64B |
June 30, 2012 | 11.59B |
March 31, 2012 | 12.14B |
December 31, 2011 | 9.866B |
September 30, 2011 | 13.20B |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
1.40B
Minimum
Dec 2019
19.09B
Maximum
Jun 2022
10.80B
Average
10.52B
Median
Gross Profit (Quarterly) Benchmarks
Amgen Inc | 5.084B |
Gilead Sciences Inc | 5.024B |
Johnson & Johnson | 14.60B |
Eli Lilly and Co | 7.565B |
Moderna Inc | 1.884B |